EFFECTS OF ANTI ANXIETY DRUG MIDAZOLAM AS PRETREATMENT THERAPY FOR ANXIETY OF ZEBRA FISHES INDUCED BY THE EXPOSURE OF UNFAMILIAR ENVIRONMENT OF AQUATIC WHITE/BLACK MAZE
Abstract
Objectves: The objective of our present research investigation was to evaluate the effectiveness of the aquatic white/black plus maze model to
evaluate the efficacy of different treatment drugs on zebra fish behavior studies.
Methods: Animals were divided into three groups each containing six animals. The first two groups were pretreated with lower and higher doses of
midazolam and then they were exposed to unfamiliar environments of aquatic white/black plus maze. The last group of animals was only immersed
into the unknown familiar in the form of aquatic white/black plus maze without any pretreatment of the drugs.
Results: The results illustrated that the pretreatment drugs certainly improved the behavior status of the animal in the form of releasing anxiety and
stress, but the doses of different pretreatment have no significant effects on improvement of behavioral status.
Conclusion: In conclusion, it can be described that this model is highly effective to find the proper drug for the treatment of anxiety but it is not so
effective to find the proper dose of treatment.
Keywords: Midazolam, Zebra fish, White/black maze, Anti anxiety, Pretreatment therapy.
Downloads
References
Zon LI, Peterson RT. In vivo drug discovery in the zebrafish. Nat Rev Drug Discov 2005;4(1):35-44.
Mueller T, Vernier P, Wullimann MF. The adult central nervous cholinergic system of a neurogenetic model animal, the zebrafish Danio rerio. Brain Res 2004;1011(2):156-69.
Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, Tiittula A, et al. Modulatory neurotransmitter systems and behavior: Towards zebrafish models of neurodegenerative diseases. Zebrafish 2006;3(2):235-47.
Dooley K, Zon LI. Zebrafish: A model system for the study of human disease. Curr Opin Genet Dev 2000;10:252-6.
Norcross M, Mathur P, Enoch AJ, Karlsson RM, Brigman JL, Cameron HA, et al. Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice. Psychopharmacology (Berl) 2008;200(3):413-24.
Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009;205(1):38-44.
Bencan Z, Sledge D, Levin ED. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009;94(1):75-80.
Sackerman J, Donegan JJ, Cunningham CS, Nguyen NN, Lawless K, Long A, et al. Zebrafish behavior in novel environments: Effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychol 2010;23(1):43-61.
Fogarty JN, Vogel-Sprott M. Cognitive processes and motor skills differ in sensitivity to alcohol impairment. J Stud Alcohol 2002;63(4):404-11.
Colwill RM, Raymond MP, Ferreira L, Escudero H. Visual discrimination learning in zebrafish (Danio rerio). Behav Processes 2005 31;70:19-31.
Arthur D, Levin ED. Zebrafish (Danio rerio). Anim Cogn 2001;4:125‑31.
Guo S. Linking genes to brain, behavior and neurological diseases: What can we learn from zebrafish? Genes Brain Behav 2004;3(2):63‑74.
Drapier D, Bentué-Ferrer D, Laviolle B, Millet B, Allain H, Bourin M, et al. Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 2007;176(2):202-9.
Serra EL, Medalha CC, Mattioli R. Natural preference of zebrafish (Danio rerio) for a dark environment. Braz J Med Biol Res 1999;32(12):1551-3.
Speedie N, Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behav Brain Res 2008;188(1):168-77.
Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on. Neurosci Biobehav Rev 2005;29(8):1193-205.
Lapiz-Bluhm MD, Bondi CO, Doyen J, Rodriguez GA, Bédard-Arana T, Morilak DA. Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats. J Neuroendocrinol 2008;20(10):1115-37.
Levin ED, Bencan Z, Cerutti DT. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 2007;90(1):54-8.
Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam. A review of its pharmacological properties and therapeutic use. Drugs 1984;28(6):519-43.
Bolon M, Bastien O, Flamens C, Paulus S, Boulieu R. Midazolam disposition in patients undergoing continuous venovenous hemodialysis. J Clin Pharmacol 2001;41(9):959-62.
Longhi R, Corbioli S, Fontana S, Vinco F, Braggio S, Helmdach L, et al. Brain tissue binding of drugs: Evaluation and validation of solid supported porcine brain membrane vesicles (TRANSIL) as a novel high-throughput method. Drug Metab Dispos 2011;39(2):312-21.
Praskova E, Voslarova E, Siroka Z, Plhalova L, Macova S, Marsalek P, et al. Assessment of diclofenac LC50 reference values in juvenile and embryonic stages of the zebrafish (Danio rerio). Pol J Vet Sci 2011;14(4):545-9.
OECD. Guideline for Testing of Chemicals (No 203), Fish Acute Toxicity Test. Paris, France: OECD; 1992.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.